Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome.
Compagno M, Navarra A, Campogiani L, Coppola L, Rossi B, Iannetta M, Malagnino V, Parisi SG, Mariotti B, Cerretti R, Arcese W, Goletti D, Andreoni M, Sarmati L. Compagno M, et al. Among authors: arcese w. Int J Environ Res Public Health. 2022 Aug 27;19(17):10693. doi: 10.3390/ijerph191710693. Int J Environ Res Public Health. 2022. PMID: 36078409 Free PMC article.
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
Locasciulli A, Bruno B, Alessandrino EP, Meloni G, Arcese W, Bandini G, Cassibba V, Rotoli B, Morra E, Majolino I, Alberti A, Bacigalupo A; Italian Cooperative Group for Blood and Marrow Transplantation. Locasciulli A, et al. Among authors: arcese w. Bone Marrow Transplant. 2003 Feb;31(4):295-300. doi: 10.1038/sj.bmt.1703826. Bone Marrow Transplant. 2003. PMID: 12621466
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
Cerva C, Colagrossi L, Maffongelli G, Salpini R, Di Carlo D, Malagnino V, Battisti A, Ricciardi A, Pollicita M, Bianchi A, Picardi A, Cudillo L, Cerretti R, De Angelis G, Cantonetti M, Andreoni M, Perno CF, Arcese W, Svicher V, Sarmati L. Cerva C, et al. Among authors: arcese w. Clin Microbiol Infect. 2016 Nov;22(11):946.e1-946.e8. doi: 10.1016/j.cmi.2016.07.021. Epub 2016 Jul 27. Clin Microbiol Infect. 2016. PMID: 27475741 Free article.
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients.
Cerva C, Salpini R, Alkhatib M, Malagnino V, Piermatteo L, Battisti A, Bertoli A, Gersch J, Holzmayer V, Kuhns M, Cloherty G, Ferrari L, Laura C, Teti E, Cantonetti M, Arcese W, Ceccherini-Silberstein F, Perno CF, Andreoni M, Svicher V, Sarmati L. Cerva C, et al. Among authors: arcese w. Biomedicines. 2022 Feb 14;10(2):443. doi: 10.3390/biomedicines10020443. Biomedicines. 2022. PMID: 35203653 Free PMC article.
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.
Sarmati L, Andreoni M, Antonelli G, Arcese W, Bruno R, Coppola N, Gaeta GB, Galli M, Girmenia C, Mikulska M, Pane F, Perno CF, Picardi M, Puoti M, Rambaldi A, Svicher V, Taliani G, Gentile G. Sarmati L, et al. Among authors: arcese w. Clin Microbiol Infect. 2017 Dec;23(12):935-940. doi: 10.1016/j.cmi.2017.06.023. Epub 2017 Jun 29. Clin Microbiol Infect. 2017. PMID: 28668466 Free article.
Granulocyte-mobilized bone marrow.
Arcese W, De Angelis G, Cerretti R. Arcese W, et al. Curr Opin Hematol. 2012 Nov;19(6):448-53. doi: 10.1097/MOH.0b013e32835903ab. Curr Opin Hematol. 2012. PMID: 22954729 Review.
322 results